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Summary
The tumour-like growth of larval Echinococcus multilocularis tissue (causing
alveolar echinococcosis, AE) is directly linked to the nature/orientation of
the periparasitic host immune-mediated processes. Parasite-mediated
immune suppression is a hallmark triggering infection outcome in both
chronic human and murine AE. So far, little is known about secondary
systemic immune effects of this pathogen on other concomitant dis-
eases, e.g. endogenous gut inflammation. We examined the influence of
E. multilocularis infection on murine dextran sodium sulphate (DSS) -
induced colitis. At 3 months after E. multilocularis infection (chronic
stage), the mice were challenged with 3% DSS in the drinking water for
5 days plus subsequently with tap water (alone) for another 4 days. After
necropsy, fixed tissues/organs were sectioned and stained with haema-
toxylin & eosin for assessing inflammatory reactions. Cytokine levels were
measured by flow cytometry and quantitative RT-PCR. Colitis severity
was assessed (by board-certified veterinary pathologists) regarding (i)
colon length, (ii) weight loss and (iii) a semi-quantitative score of mor-
phological changes. The histopathological analysis of the colon showed a
significant reduction of DSS-induced gut inflammation by concomitant
E. multilocularis infection, which correlated with down-regulation of T
helper type 1 (Th1)/Th17 T-cell responses in the colon tissue. Echinococ-
cus multilocularis infection markedly reduced the severity of DSS-induced
gut inflammation upon down-regulation of Th1/Th17 cytokine expression
and attenuation of CD11b+ cell activation. In conclusion, E. multilocularis
infection remarkably reduces DSS-induced colitis in mice by attenuating
Th1/Th17-mediated immune reactions.
Keywords: inflammation; parasitic-helminth; T helper type 1/type 17 cells.
Introduction
Alveolar echinococcosis (AE) is a very severe zoonotic
helminthic disease in humans, which is fatal if not appro-
priately treated.1 AE is characterized by chronic and pro-
gressively developing hepatic damage caused by the
continuously proliferating parasite tissue (metacestode) of
Echinococcus multilocularis,2 clinically mimicking a slowly
growing and metastasizing liver cancer.3 The type of
immune response elicited during E. multilocularis infec-
tion predetermines the outcome of infection (resistance
versus susceptibility)4 and, if disease occurs, the kinetics
of progression of disease.5 In humans, T helper type 2
(Th2) -oriented immunity is associated with increased
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susceptibility to disease, leading to chronic AE, whereas
Th1 cell activation has been linked to reduced or abro-
gated metacestode proliferation, or even protection,
which occurs when the parasite becomes aborted, result-
ing in ‘died-out’ lesions.2,3 Experimental murine AE is
immunologically characterized by an initial Th1-oriented
response during the early stage of infection (till approxi-
mately 1 month after infection), which gradually acquires
a greater Th2 emphasis alongside Th1 activation, so
becoming a mixed Th1/Th2 response during the chronic
phase of AE (2–4 months after infection). This mixed
Th1/Th2 profile in immunocompetent mice is associated
with the expression of pro-inflammatory cytokines in the
periparasitic granuloma and partial/relative protective
immunity (restriction of parasite growth) through fibrosis
and necrosis,6 whereas in immunodeficient hosts uncon-
trolled susceptibility results in an extremely rapid pro-
gressing parasite proliferation.7–9 It has been previously
reported that CD4+ CD25+ T regulatory (Treg) cells
appeared quantitatively up-regulated in human AE. It was
also shown that this up-regulation is associated with the
blunting of the immune response to specific antigens,
and/or to the suppression of the secretion of pro-inflam-
matory cytokines, especially through high interleukin-10
(IL-10) and transforming growth factor-b1 (TGF-b1) pro-
duction in cystic echinococcosis.10 In the experimental
mouse model, increased CD4+ CD25+ Treg cells were also
observed within the peritoneal cell population. Such
results concurred with other findings to demonstrate that
E. multilocularis antigens promote T-cell differentiation
into Treg cells11 and so finally induce immune tolerance
and anergy towards the parasitic infection.
The ‘hygiene hypothesis’ proposes that the stimulation
of the immune system by microbes or microbial products
protects from the development of inflammatory diseases.
Reflecting the anti-inflammatory actions of parasite-
derived immunomodulators, an inverse correlation exists
between helminthic infections and the occurrence of
autoimmune diseases, best documented in the industrially
developed world.12 Furthermore, it has become evident
that many helminthic infections are associated with
reduced allergic reactivities, and most respective studies
demonstrated an increased Treg cell activity in infected
murine or human hosts.13
Crohn’s disease and ulcerative colitis are the main and
distinct clinical and pathophysiological entities of inflam-
matory bowel diseases (IBD).14 Current evidence suggests
that aberrant immune reactions against intestinal lumen-
derived microbial antigens can lead to their onset in
genetically susceptible individuals.15 During the last
15 years, the therapy of patients with IBD was revolution-
ized with the development of specific biologicals, notably
of tumour necrosis factor (TNF) inhibitors of various
types.16,17 However, approximately 20% of patients do
not respond to anti-TNFs, and over 30% eventually lose
response.16,18,19 In addition, these biological compounds
and the often-associated chemical immunosuppressants have
been shown to be responsible for adverse effects and
especially for increasing the risk of infections and malig-
nancies.20,21
Much experimental data support the hypothesis that
helminths are able to modulate colitis. The possible bene-
ficial effect of helminth infections on the development
and course of colitis has been investigated in different
animal models.22 It was shown that an infection with
Schistosoma mansoni cercariae exerted preventive effects
on the course of trinitrobenzene sulphonic acid (TNBS) -
induced colitis in rats and dextran sodium sulphate
(DSS) -induced colitis in mice.14,23,24 Furthermore,
S. mansoni eggs prevented mice from developing TNBS-
induced colitis, but did not prevent mice from developing
DSS colitis.15,24 Schistosoma japonicum eggs also exerted
preventive effects on TNBS-induced colitis in mice.16,17 A
previous infection of mice with Trichinella spiralis larvae
and Trichinella papuae larvae reduced the severity of
DNBS-induced and DSS-induced colitis, respectively.18,19
Infection with Hymenolepis diminuta larvae in DNBS
mice had a profound anti-colitis effect (both prophylacti-
cally and as a treatment), which was not seen in
semi-permissive rats.20,21 In contrast, Heligmosomoides
polygyrus bakeri larvae enhanced Citrobacter rodentium-
induced infectious colitis in mice,25,26 and Hymenolepis
diminuta infection caused an exacerbation of oxazolone-
induced colitis in mice.27,28 Soon after the first promising
findings of helminth infections on experimental colitis
were published, clinical trials were started to explore
whether helminths could alter the course of disease in
patients, with the use of the pig whipworm Trichuris
suis29–31 and larvae of the human hookworm Necator.32
After these promising results, the US Food and Drug
Administration requested the development of T. suis ova
under good manufacturing practice and appropriate
safety testing in order to continue clinical tests.33 Hel-
minthic immunomodulators therefore may be highly
attractive molecules with great potential to be used
as therapeutic compounds for the treatment of colitis, as
exemplified by the recent development of a transgenic
probiotic secreting cystatin, an immunomodulator from
nematodes, for site-directed treatment of gut
inflammation.34
However, in clinical trials, the use of intestinal hel-
minths/helminth eggs was not as convincing in patients
with IBD as in the experimental models;35 this could be
due to the schedule of administration and/or the volun-
tary use of low doses of worms to limit possible adverse
effects. Other types of helminths and/or their products
could be an alternative. Regarding the influence of ces-
tode infections on immunologically mediated diseases, it
has been shown that, in experimental models, Echinococ-
cus granulosus infection reduced airway inflammation36
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and also alleviated the severity of experimental DSS-
induced colitis.37 However, the influence of E. multilocu-
laris, which generates a more complex and sustained
immunoregulatory profile than E. granulosus, has never
been studied, and the role of systemic T-cell regulation,
its related cytokine production, and antigen-presenting
process have not been clarified.
The major aims of the present study were: (i) to address
whether infection by the cestode E. multilocularis could
modulate the phenotype of the well-known DSS-induced
colitis; and (ii) to further explore possible mechanisms that
would explain the immunotherapeutic properties of
E. multilocularis infection acting on DSS-induced colitis.
To achieve these goals, we investigated the differential
levels of pathological changes in the colon and its related
pro-inflammatory/inflammatory cytokines, Th1/Th2 and
Treg/Th17-related cytokine expression levels in both spleen
and colon, together with CD11b+ CD11c+ cell activation
in the spleen, in E. multilocularis-infected mice
subsequently challenged with a DSS-induced colitis.
Materials and methods
Ethical statements
The animal study was performed in strict accordance with
the requirements of the Swiss Guidelines for the Care and
Use of Laboratory Animals. The protocol was approved
by the governmental Commission for Animal Experimen-
tation of the Canton of Bern (approval nos BE103/11 and
BE112/14).
Experimental design, parasite sampling and histological
examination
Mice. Female C57BL/6 mice, all aged between 8 and
10 weeks, were bred and housed under specific pathogen-
free conditions according to recommendations of the
Federation of European Laboratory Animal Science Asso-
ciation, and additionally monitored by daily inspection,
including the assessment of the appearance of health sta-
tus, putative weight loss or gain during the whole course
of the experiment. Facility supervision for infectious dis-
eases specifically included also the demonstration of
absence of Helicobacter, Citrobacter, norovirus, rotavirus
and Oxyuris. All experiments with animals were per-
formed within a laminar flow safety enclosure. The mice
were randomly divided into four groups with six mice in
each group comprising: (i) negative control group (NC);
(ii) E. multilocularis infection group (Em); (iii) DSS-
induced colitis group (DSS); (iv) E. multilocularis infec-
tion plus DSS-induced colitis group (Em+DSS).
Parasite and experimental infection. Echinococcus multi-
locularis (H95) was isolated and maintained by serial
passages (vegetative transfer) in C57BL/6 mice as previ-
ously described.38 In order to prepare the infection mate-
rial for mice, metacestode tissue was obtained from
previously infected mice by aseptic removal from the
peritoneal cavity. After grinding the tissue through a ster-
ile 50-lm sieve, approximately 100 freshly prepared vesic-
ular cysts were suspended in 100 ll RPMI-1640 (Gibco,
Basel, Switzerland) and injected intraperitoneally.
DSS-induced colitis. At 3 months after E. multilocularis
infection, or in non-infected mice used as controls, exper-
imental acute colitis was induced by administration of
3% 36 000–50 000 MW DSS (MP Biomedical, Solon,
OH) in the drinking water for 5 days, followed by 4 days
of regular tap water, animals were finally killed at day 9.
Collection of host tissue. Mice were killed by Isofluran
anaesthesia followed by CO2 euthanasia. Blood was col-
lected by cardiac puncture, and serum samples were
stored at 80°.
Colonic cells. Approximately 15-cm lengths of the ante-
rior colons were opened longitudinally and cut into small
pieces. The epithelium was removed by incubation in
Hanks’ balanced salt solution/HEPES containing 5%
horse serum, 5 mM EDTA and 2 mM dithiothreitol at 37°
for 30 min under magnetic stirring. Colonic cells were
obtained by subsequent digestion with 200 U/ml collage-
nase (Type IV; Sigma-Aldrich, St Louis, MO, USA) and
50 U/ml DNase (Type I, grade II; Roche, Basel, Switzer-
land) for 45 min, then filtered through a 40-lm cell strai-
ner, counted using Trypan Blue staining and further
characterized by quantitative RT-PCR.
Histopathology and histopathological grading. Sternum,
thymus, part of the spleen, mesenteric lymph nodes, and
small and large intestine from each mouse were fixed in
10% neutral-buffered formalin for 24 hr and embedded
in paraffin. Blocks were sectioned and slides were stained
with haematoxylin & eosin. On haematoxylin & eosin-
stained sections, morphological changes of all tissues were
recorded and a semi-quantitative grading was used to
score bone marrow, spleen and colon as listed in Table 1.
The disease activity index (DAI) for the DSS-induced col-
itis scoring system is summarized in Table 2. The macro-
scopic and microscopic evaluations were performed in a
blinded fashion by European-board-certified veterinary
pathologists.
Cell preparations. Spleen cells were collected by grinding
individual organs separately with 5 ml RPMI-1640. Cells
were subsequently washed twice and resuspended in
RPMI-1640 (Gibco). Macrophages were removed from
each group of mice by plastic adhesion after incubation
of spleen cell suspension in 15 ml RPMI-1640 + 20%
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fetal calf serum in a Petri dish for 2 hr at 37°, in an
atmosphere containing 5% CO2. Subsequent to incuba-
tion, non-adherent cells were separated from macro-
phage-enriched adherent cells, and this new cell
suspension was used for FACS analyses.
Flow cytometry
Aliquots of 105 cells/100 ll of staining buffer per well
were incubated each with 1 lg of purified anti-CD16/
CD32 for 20 min in the dark to block non-specific bind-
ing of antibodies to the FccIII and FccII receptors. Subse-
quently, these cells were separately stained with the
following surface markers for 15 min with 1 lg of pri-
mary antibodies: allophycocyanin-labelled anti-CD4, anti-
CD80, anti-CD86; phycoerythrin-labelled anti-CD11b,
anti-CD11c. All antibodies were from eBioscience (San
Diego, CA). For intracellular staining, peritoneal exudate
cells (PECs) or spleen cells were first incubated with
Inside Fix (Miltenyi Biotec, Bergisch Gladbach, Germany)
for 20 min at room temperature and subsequently stained
with phycoerythrin-labelled anti-interferon-c (IFN-c),
anti-IL-4, anti-IL-17A, anti-IL-10 and anti-Foxp3 (eBio-
science) in Inside Perm (Miltenyi Biotec) for 15 min in
the dark. Corresponding fluorochrome-labelled isotype
control antibodies were used for staining controls. Cells,
resuspended in 300 ll of buffer (015 M NaCl, 1 mM
NaH2PO4 H2O, 10 mM Na2HPO4 2H2O and 3 mM
NaN3) were analysed in a flow cytometer (Becton
Dickinson, Heidelberg, Germany) using the correspond-
ing CELL QUEST software.
Cytokine gene-expression analyses by quantitative
RT-PCR
Total RNA was extracted from spleen or colon tissue pre-
viously put into TRIzol (Invitrogen) according to the
manufacturer’s instructions. The cDNA was synthesized
using the Omniscript Reverse Transcription kit (Qiagen,
Hilden, Germany). SYBR-Green Mix-based quantitative
RT-PCR was carried out on a Rotor-Gene 6000 quantita-
tive PCR detection system (Corbett, Sydney, Australia)
with the FastStart Essential DNA Green Master (Roche)
following the manufacturer’s instructions. PCR cycling
was performed in triplicates in final volumes of 20 ll con-
taining 2 ll cDNA and 10 pM of each primer (Cycle
scheme: initial denaturation at 95° for 15 min, 45 cycles of
95° for 15 seconds, 55° for 30 seconds and 72° for 30 sec-
onds). Fluorescence was measured in every cycle, and a
melting curve was analysed after the PCR by increasing
the temperature from 55° to 95° in 05° increments. The
primers used were described earlier,39 and cytokine mRNA
levels were quantified relative to the mRNA level of the
housekeeping gene b-actin. Respective mean values from
triplicate determinations from six individual mice in each
group were taken for the calculation of relative cytokine
mRNA levels in relation to b-actin mRNA levels.
Statistical analyses
All data were analysed by SPSS 17.0 (IBM Corporation,
Armonk, New York, USA). The results are presented as
means  SD. Normality of data was assessed by D’Agos-
tino & Pearson and Shapiro–Wilk test. For normally dis-
tributed groups of data, one-way analysis of variance
followed by Bonferroni’s post-test or unpaired two-tail Stu-
dent’s t-test were used to compare the differences between
groups. Significance was defined as P < 005 for all tests,
except those subsequently corrected by Bonferroni.
Table 1. Histopathological scores to quantify changes in different organ systems
Organ Criterion
Score
0 1 2 3 4
Bone
marrow
Ratio myelopoiesis/erythropoiesis 3–4 : 1 5 : 1 6–10 : 1 11–25 : 1 > 25 : 1
Spleen % increase in extramedullary
haematopoiesis
No increase < 25 26–50 51–75 76–100
Colon Inflammation No pathological
change
Mild infiltrates of
inflammatory cells
in the lamina propria
without
erosion/ulceration
Marked inflammation
and deep ulceration
with
crypt abscesses
Additional
epithelial
dysplasia and/or
neoplasia
–
Table 2. Disease activity index (DAI) for dextran sodium sulphate
(DSS) -induced colitis
Weight
loss Score Stool blood Score Stool consistency Score
< 1% 0 Absence 0 Formed and hard 0
1–5% 1 Formed but soft 1
5–10% 2 Presence 2 Loose stools 2
10–15% 3 Mild diarrhoea
(watery)
3
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Results
Echinococcus multilocularis infection reduces severity
of DSS-induced colitis in mice
To evaluate the benefits of E. multilocularis infection in
abrogating or down-regulating colitis, we subjected mice to
DSS-induced colitis 3 months after E. multilocularis infec-
tion. With administration of 3% DSS, the Em + DSS
groups (E. multilocularis infection combined with chal-
lenge with 3% DSS) exhibited less severe symptoms includ-
ing body weight losses, DAI scores and colon length
changes compared with the DSS group (challenge with 3%
DSS) (Fig. 1). The body weight in the DSS group (acute
colitis model) decreased significantly when compared with
the negative control (NC) groups, whereas body weight loss
was much lower in the Em+DSS group (Fig. 1a). The DAI
scores were significantly lower in the Em+DSS group when
compared with those of the DSS group (Fig. 1b). Similarly,
the average colon length of the DSS group was shortened
by approximately 24% when compared with that of the NC
groups, whereas it was only reduced by about 4% in mice
of the Em+DSS group (Fig. 1c). These results suggest that
E. multilocularis infection reduces the severity of colitis.
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Figure 1. Mice chronically infected with Echinococcus multilocularis are protected from dextran sodium sulphate (DSS) -induced colitis. (a)
Weight loss relative to the initial body weight. Mean values of n = 15 to n = 18 mice analysed per group are shown with error bars indicating
the SD. At 3 months after E. multilocularis infection, experimental colitis was induced by administration of 3% DSS in the drinking water for
5 days followed by 4 days of regular tap water. Day 1, 2, 3, 4 indicates the days after tap water. (b) Disease activity index (DAI) changes among
groups after 9 days 3% DSS treatment at the end time-point. Data represents the mean  SD (n = 15 to n = 18). (c) Colon lengths were deter-
mined in individual mice. Data show mean values for each group of mice. (d–g) Individual parameters of histopathological scoring. (d) Lymph
follicles in the colon. (e) Increase in granulopoiesis in the bone marrow. (f) Lymphoid structures in the spleen. (g) Extramedullary haematopoi-
esis in the spleen. Histopathological scores were determined for individual mice by a pathologist according to parameters defined in the Materials
and methods section. Columns show mean values for n = 5 or n = 6 mice analysed per group and error bars indicate the SD. One representative
experiment out of three independent experiments is shown. HPF, high-power field; EMH, extramedullary haematopoiesis. *P < 005.
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Histopathological effects of E. multilocularis infection
on DSS-induced colitis in mice
Significant morphological changes were recorded in the
bone marrow and lymphoid organs of the Em group and
of the Em+DSS group when compared with the NC and
DSS groups (Fig. 1d–g). In detail, the ratio of granulo-
cytic to erythrocytic precursor cells in the bone marrow
was scored 0 (no pathological change) in the NC group,
2 (mild increase) in the DSS group and grade 3 (moder-
ate increase) in groups with Em or Em+DSS, respectively
(mean values) (Fig. 1e). Reduced numbers of periarterio-
lar lymphoid sheaths were noted in the Em and Em+DSS
groups in comparison to the NC and DSS groups
(Fig. 1f). Additionally, a significant increase in extrame-
dullary haematopoiesis was noted in the spleen of all ani-
mals from the Em and Em+DSS groups compared with
the NC and DSS groups (Fig. 1g), corresponding to a
marked increase in organ weight (data not shown). The
large intestine was significantly altered in all animals from
the DSS group, displaying multifocal epithelial necrosis
and mucosal ulceration, loss of goblet cells, loss and/or
proliferation of crypts, crypt abscesses and marked infil-
tration of the lamina propria by macrophages, neu-
trophils and lymphocytes, and finally fibrosis (grade 2,
Fig. 2). Besides these findings, five animals also revealed
epithelial dysplasia/proliferation (grade 3, Fig. 2). In com-
parison, the large intestine from animals of groups Em
and Em+DSS presented fewer lymph follicles in the
mucosa and/or submucosa (grade 1, Fig. 2), and no
pathological changes were noted in the NC group (grade
0) (Figs 1d and 2).
Echinococcus multilocularis infection reduces DSS-
induced inflammatory/pro-inflammatory cytokine
expression in the colons of mice
Cytokines are principal mediators of the innate and adap-
tive arms of the immune responses in mucosal inflamma-
tion. To analyse the influence of the cytokine patterns in
DSS-induced colitis mice and the effect of E. multilocu-
laris infection on DSS-induced colitis pathogenesis, the
cytokine profile in the colon of the mice was measured
by quantitative RT-PCR. In general, a marked up-regula-
tion in the pro-inflammatory/Th1 cytokine (IL-12, IFN-c,
IL-1b, IL-6, TNF-a) and Th17 cytokine (IL-17A) mRNA
expression level was observed in the DSS group (Fig. 3).
Interestingly, a significant decrease of those cytokine
expression levels (IL-12, IFN-c, IL-6, TNF-a, IL-17A,) was
noted in the colon of the Em+DSS group, when com-
pared with the DSS group. Interleukin-1b, responsible for
inducing the inflammatory cascade, was not differentially
expressed in the colon of the Em+DSS group, when com-
pared with DSS group (Fig. 3). There was no difference
in IL-4 mRNA level between the colons of the Em+DSS
and the DSS groups (data not shown).
Echinococcus multilocularis infection changed immune
direction in the spleen from mice with DSS-induced
colitis
To further explore the effect of E. multilocularis infection
on the systemic T-cell immune response in DSS-induced
colitis in mice, T helper-related cytokines were compara-
tively assessed in all the groups (Em, DSS, Em+DSS, and
NC Em DSS Em+DSS
Figure 2. Representative histopathological findings in the colon [haematoxylin & eosin (H&E) staining]. Representative histopathological changes
of the colon [H&E stain, magnification 1009 (first row) and 4009 (second row)]. Distension of mucosa and submucosa by infiltration of
inflammatory cells, fibrosis, loss and proliferation of crypts in dextran sodium sulphate (DSS) group compared with a regular colon without
pathological changes in NC, Em and Em+DSS groups. Higher magnification reveals ulceration of the mucosal epithelium with infiltration of neu-
trophils (asterisk) and lymphocytes in the depth of the lamina propria mucosae (arrow). [Colour figure can be viewed at wileyonlinelibrary.com]
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in their respective NC controls). Flow cytometry revealed
that Th cells from the Em group were oriented towards
the Treg/Th2 pathway at the chronic stage of E. multiloc-
ularis infection (Em group), with high expression levels
of IL-10, Foxp3 and IL-4 (Fig. 4), whereas DSS induced
significantly increased expression levels of IFN-c when
compared with the NC group. CD4+ T cells from
Em+DSS mice were oriented towards a Treg pathway,
with high expression levels of IL-10 and Foxp3 in the
spleen. Conversely, a lower IFN-c expression level was
found in the Em+DSS group when compared with the
DSS group (Fig. 4).
Echinococcus multilocularis infection reduces antigen-
presenting cell activation and co-stimulation in the
spleen from mice with DSS-induced colitis
To further explore the effect of E. multilocularis infection
on antigen-presenting cell activation and co-stimulation
signals for T cells, we measured CD80, CD86 and CD40
in CD11b+ and CD11c+ cells. Flow cytometry showed
that the frequency of maturation markers CD80 and
CD86 was higher in CD11c+ cells (Fig. 5a–d), and the
frequency of T-cell co-stimulation marker CD40 was
lower in CD11c+ cells in the Em group than in the NC
group (Fig. 6a,b). However, there was no difference either
in CD80 and CD86 frequency (Fig. 5a–d), or in CD40
frequency among CD11b+ cells in these groups (Fig. 6a,
b). However, DSS challenge led to a significantly
increased expression level of CD80, CD86 and CD40 in
CD11b+ cells when compared with the NC group (Figs 5
and 6). Conversely, in the Em+DSS group, CD80, CD86
and CD40 levels in CD11b+ cells were significantly lower
when compared with the DSS group (Figs 5 and 6).
However, there was no difference in the CD80, CD86 and
CD40 frequencies among CD11c+ cells between groups
DSS and Em+DSS (Figs 5 and 6).
Discussion
Inflammatory bowel diseases are complex diseases caused
by a deregulated immune response to intestinal luminal
antigens,15 and have increased at an alarming rate in the
past two decades.40–45 Symptoms of IBD are the result of
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Figure 3. Colonic inflammation was attenuated in mice with alveolar echinococcosis (AE) regarding dextran sodium sulphate (DSS-induced coli-
tis. Inflammatory/inhibitory cytokine gene expression levels in the colon of mice (measured by quantitative RT-PCR). AU, arbitrary units.
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with Bonferroni’s multiple comparison post-test for statistical analysis. *P < 0004.
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complex interactions among genetic and environmental
factors, and the immune response.46,47 Nowadays, therapy
with immunomodulating biological agents is consid-
ered the mainstay for moderate-to-severe Crohn’s disease
and severe ulcerative colitis.16 The anti-TNFs infliximab
and adalimumab have been extensively used and shown
to induce clinical and endoscopic remission in both dis-
eases.16 Nevertheless, some patients do not respond ini-
tially or, more frequently, lose response. Recently, other
biological agents targeting other immunological pathways
were approved for the treatment of IBD, such as vedoli-
zumab, an a4b7 anti-integrin that impairs gut homing of
lymphocytes in Crohn’s disease and ulcerative colitis,37
and ustekinumab, a bivalent anti-IL-12–IL-23 monoclonal
antibody for Crohn’s disease.38 Other promising
therapeutic biologicals targeting specific cellular metabolic
pathways are currently in phase III stage of research, such
as orally administered janus kinase inhibitors (tofacitinib)
in ulcerative colitis,39 or a SMAD7 oral anti-sense
oligonucleotide (Mongersen) that down-regulates inflam-
matory cytokine production by restoring TGF-b1/Smad
signalling in Crohn’s disease .40 However, altogether these
drugs have potential deleterious and sometimes unpre-
dictable paradoxical effects on the immune system and
new therapeutic approaches are eagerly awaited. Faecal
transplantation has shown promising results in ulcerative
colitis and opens a new ‘pathophysiological era’ in IBD
treatment management but its long-term efficacy and
modalities of administration are debated.41 Therefore, it
is still important to look for other therapeutic pathways
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against IBD, and systemic immune modulation induced
by parasite-derived compounds is one of these innovative
pathways.
Epidemiological observations showed an association
between (i) the decrease in infectious diseases, including
parasite infections, use of antibiotics, vaccinations and a
general improvement in food, water and housing sanitary
conditions; and (ii) an increase in the incidence of aller-
gic diseases, and also autoimmune and chronic inflamma-
tory disorders.48 This finding forms the basis of the
continually revisited ‘hygiene hypothesis’.43 Within this
hypothesis, intestinal worms could play a role by
modulating the composition/function of the gut micro-
biota, which is fundamental to the ‘education’ of the
immune system after birth; all types of helminths, includ-
ing their larval stage in organs other than the gut, might
also play a role in the systemic immune balance that pre-
vents abnormal inflammation.43 Several experimental
studies using different animal models of colitis have
shown the ability of parasitic worms to attenuate intesti-
nal inflammation,28–33 e.g. T. suis exerts a therapeutic
effect in patients with ulcerative colitis and Crohn’s dis-
ease.29–31,49 Although a large body of evidence indicates
that regulatory mechanisms that reduce IBD severity may
60·0 CD11c CD80
CD11b CD80 CD80
(a)
*
*
*50·0
40·0
30·0
20·0
10·0
0·0
0·0
10·0
20·0
30·0
40·0
50·0 25·0
20·0
15·0
10·0
5·0
0·0
50·0 40 000
30 000
20 000
10 000
M
ea
n 
flu
or
es
ce
nc
e
in
te
ns
ity
 (M
F)
0
40·0
30·0
20·0
10·0
0·0CD
80
+
 
in
 C
D1
1c
+
 
ce
lls
 (%
)
CD
86
+
 
in
 C
D1
1c
+
 
ce
lls
 (%
)
CD
86
+
 
in
 C
D1
1b
+
 
ce
lls
 (%
)
M
ea
n 
flu
or
es
ce
nc
e
in
te
ns
ity
 (M
FI)
CD
80
+
 
in
 C
D1
1b
+
 
ce
lls
 (%
)
NC
FITC-CD80
FITC-CD86
(b)
(c)
(d)
SS
C
SS
C
Em DSS
Isotype
Isotype
CD11c CD86
CD11b CD86
0·1
0·5 7·6 8·3 20·6 9·9
*
NC
NC
9·8 13·2 40·1
Em
Em
DSS
DSS
Em+DSS
NC Em DSS Em+DSS NC Em DSS Em+DSS NC
0
10 000
20 000
30 000
40 000 CD86
*
Em DSS Em+DSS
NC Em DSS Em+DSS NC Em DSS Em+DSS
Em+DSS
Em+DSS
15·2
0–103 103 104 105 0–103 103 104 105 0–103 103 104 105 0–103 103 104 105 0–103 103 104 105
0–103 103 104 105 0–103 103 104 105 0–103 103 104 105 0–103 103 104 105 0–103 103 104 105
250 k
200 k
150 k
100 k
50 k
0
250 k
200 k
150 k
100 k
50 k
0
Figure 5. Antigen-presenting cell (APC) activation was attenuated in the spleen of mice with alveolar echinococcosis (AE) upon dextran sodium
sulphate (DSS) -induced colitis. Cells were first gated on size and singularity followed by DAPI exclusion to identify live cells for further analysis.
Live cells were gated on CD11b or CD11c expression to first identify CD11b+ and CD11c+ cells. Then phycoerythrin-labelled CD80, CD86
expression was identified as CD80, CD86 frequency within CD11c+ or CD11c+ cells. (a) CD80 frequency within CD11c+ and CD11b+ cells, CD80
mean fluorescence intensity (MFI) within CD11b+ cells in spleen cells from each group. (b) Representative images of CD80+ within CD11b+ cells
in spleen cells from each group. (c) CD86 frequency within CD11c+ and CD11b+ cells, CD86 MFI within CD11b+ cells in spleen cells from each
group. (d) Representative images of CD86+ within CD11b+ cells in spleen cells from each group. Comparison between groups was performed
using a one-way analysis of variance with Bonferroni’s multiple comparison post-test for statistical analysis. *P < 0004.
ª 2017 The Authors. Immunology Published by John Wiley & Sons Ltd., Immunology 9
E. multilocularis infection reduces colitis
be triggered by intestinal helminths, and especially nema-
tode infections, far less is known about larval cestodes,
which cannot exert a direct effect on the gut. Previous
experiments using a mouse model of cystic echinococco-
sis (E. granulosus infection) have suggested that concomi-
tant infection with E. granulosus improved the clinical
score, ameliorated the DAI, and prevented the shortening
of the colon in experimental DSS-induced colitis;37 such
improvement was associated with a reduced nitric oxide
and TNF-a production in the plasma of experimental
E. granulosus-infected mice with DSS-induced colitis and
decreased inducible nitric oxide synthase and nuclear fac-
tor-jB expression in colonic tissue. It is interesting to
note that a crude extract of the laminated layer from an
E. granulosus cyst was as able as active E. granulosus
infection to attenuate mucosal intestinal damage and
inflammatory responses in DSS-induced colitis in mice;50
in these experiments using the laminated layer, the
authors also focused on macrophage-dependent mecha-
nisms, and confirmed the reduced nitric oxide production
and inducible nitric oxide synthase expression in the
colon as well as reduced TNF-a production. However, no
complementary studies of the T-cell-related immunoregu-
latory mechanisms were performed.
Chronic infection with E. multilocularis is characterized
by a marked parasite-induced immune tolerance status
including a down-regulation of periparasitic and systemic
immunity against the metacestode both in humans51 and
in experimentally infected mice.52 Mechanisms of the
immune tolerance involved in Echinococcus spp. infection
has received more attention in AE, caused by E. multiloc-
ularis, than in cystic echinococcosis, caused by E. granulo-
sus, because it is chronically sustained and because the
rodents are the natural intermediate host of the para-
site, hence making the mouse experimental model highly
relevant.2–5 We therefore hypothesized that the negative
immune regulation observed when E. multilocularis infection
is fully established would also down-regulate DSS-induced
colon inflammation, and so prevent or repair DSS-
induced damage; this model would also allow us to
explore the T-cell-dependent immunoregulatory mecha-
nisms, which have been well delineated in the chronic
infection by E. multilocularis in mice. The results of our
first experiments fully confirm our hypothesis; taken
together, our observations suggest that a pre–established
E. multilocularis infection protects mice from DSS-
induced colitis. DSS-exposed E. multilocularis-infected
mice exhibited significantly less severe colitis than those
animals without E. multilocularis infection: colonic
improvement included maintained colorectal lengths, and
microscopically normal mucosal structures with a nearly
normal number and size of goblet cells secreting mucus,
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in marked contrast to non-infected animals with DSS-
induced colitis, suggesting that E. multilocularis, like other
helminths, can help in preserving/restoring these cells.50
Goblet cells are involved in regulating both the mucosal
barrier and the relative composition of the luminal
microbiota by mucin production.50 The production of
mucus by these cells could limit bacterial access to epithe-
lial cells and prevent chronic inflammation.50
Polymorphonuclear leucocytes such as neutrophils play
a critical role in the maintenance of intestinal homeosta-
sis. They display defence mechanisms to eliminate
microbes that have translocated across the single layer of
mucosal epithelial cells, which form a critical barrier
between the gut lumen and the underlying tissue. During
the inflammatory response, neutrophils also contribute to
the recruitment of other immune cells and facilitate
mucosal healing by releasing mediators necessary for the
resolution of inflammation. Neutrophil infiltration is a
key event in inflammation of the colon.53 Here we found
that E. multilocularis infection during DSS-induced colitis
generated a greater infiltration by monocytes than neu-
trophils, the latter being the main cell type detected in
the absence of helminth infection. Inflammatory mono-
cytes accumulate in response to infection or tissue injury,
and in most cases they help to clear pathogens.54,55 How-
ever, in IBD, the recruitment of inflammatory monocytes
into damaged tissue frequently worsens the inflamma-
tion.56 Macrophages from E. multilocularis-infected mice
have been shown to exhibit a reduced ability to present a
conventional antigen, such as ovalbumin to specific
responder lymph node T cells, when compared with nor-
mal macrophages from non-infected mice; this triggers an
unresponsiveness of T cells, which in turn leads to the
suppression of their clonal expansion during the chronic
phase of E. multilocularis infection.57 High periparasitic
nitric oxide production by peritoneal exudate cells,
mainly macrophages, were also shown to contribute to
E. multilocularis-induced immunosuppression.58,59 Func-
tionally modified macrophages might therefore play a
critical role in avoiding colonic inflammation and per-
haps inhibiting recruitment of inflammatory cells into the
lamina propria of the colon; the relevance of this hypoth-
esis is also supported by the results obtained in the stud-
ies with E. granulosus infection.23,49
CD4+ T cells and their associated cytokines play an
important role in the development of DSS-induced experi-
mental colitis;60 however, their role was not studied in the
E. granulosus model.47 In E. multilocularis infection, in
resistant hosts, Th1 cytokines induce a protective immu-
nity that involves IFN-a and IL-1261 as initiating cytoki-
nes, and IFN-c and TNF-a as effector cytokines.7,59 The
key-role for TNF-a in the protection of mice against
E. multilocularis infection was demonstrated by the
extreme susceptibility of TNF-a-deficient (knockout) mice
to the infection.62 The down-regulation of TNF-a
observed both in the E. granulosus23 and our E. multilocu-
laris model, associated with reduced intensity of the DCC-
induced colitis, fits well with such observations and with
the pathophysiology of experimental colitis, as well as with
the spectacular effect of anti-TNF-a biological agents in
patients with Crohn’s disease. In patients with AE and in
experimental susceptible mice, the sustained inhibition of
Th1-type effector cells as well as pro-inflammatory and
Th1-type cytokines at the chronic stage of E. multilocularis
infection is associated with up-regulation of CD4+ CD25+
Treg cells and of Th2/Treg-cell-associated cytokines and
regulatory factors.7,60 Our results in the non-DSS-chal-
lenged E. multilocularis-infected mice confirmed these
observations; conversely, our observations in DSS-chal-
lenged mice confirmed the up-regulation of Th1-type
cytokine mRNA in acute DSS-induced colitis, including
IL-12, IFN-c, IL-1b, IL-6, TNF-a and the Th17 class cyto-
kine IL-17A. In addition to TNF-a inhibition, we could
show that E. multilocularis infection markedly reduced the
expression level of Th1/Th17-related cytokines, including
IFN-c, IL-6 and IL-17A in mice with associated experi-
mental colitis. Our results showing that CD4+ T cells in
the spleen from Em+DSS mice are oriented towards a
Treg cell pathway, with low IFN-c and high IL-10 and
FoxP3 expression, strongly suggest that the clinical and
histopathological effects on colitis are actually medi-
ated through changes in the systemic immune profile of
the mice, as was suggested in experiments with other hel-
minthic infections.62 The reduced levels of the co-stimula-
tion molecules CD80, CD86 and CD40 that we observed
on CD11b+ dendritic cells in E. multilocularis infected
mice with colitis compared with the non-infected mice
similarly challenged with DSS, could be involved, at least
partially, in skewing the immune profile. Our knowledge
of TGF-b and TGF-b/Smad signalling in E. multilocularis
infection63 and of the efficacy of new biological agents that
interfere with Smad signalling in Crohn’s disease16 sug-
gests that further studies on the mechanisms of E. multi-
locularis-mediated protection against DSS-induced colitis
should focus on the TGF-b/Smad pathway.
Even more than nematode worms such as Trichuris spp.,
which have a potential for pathogenicity,64 Echinococcus
spp. metacestodes are associated with potentially severe
diseases and concomitant infection cannot represent an
alternative to the currently used therapies in IBD. Cestode-
derived compounds, and especially those derived from
E. multilocularis, might be more appropriate than real
infection with nematodes for subsequent therapeutic appli-
cation in human patients with IBD. Parasite metabolites
and/or secreted or excreted parasite molecules appear as
crucial elements in the immune modulation at the host–
parasite interface to promote parasite survival.6 For
E. multilocularis, immune modulatory effects have been
mainly attributed to E. multilocularis vesicular fluid,13 and
also to the laminated layer, which represents a highly
ª 2017 The Authors. Immunology Published by John Wiley & Sons Ltd., Immunology 11
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immunogenic mucopolysaccharide interface between the
germinal layer of the parasite and adjacent host tissue.3
Experiments using extracts of the non-infectious laminated
layer of E. granulosus are encouraging.49 At this stage,
identification and purification of the bioactive molecule(s)
responsible for the effective anti-inflammatory and thera-
peutic effects of Echinococcus spp. in colitis as well as
exploration of their safety aspects will therefore be the next
steps towards promising therapeutic agents.
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